CN106266693A - 治疗糖尿病的中药组合物 - Google Patents
治疗糖尿病的中药组合物 Download PDFInfo
- Publication number
- CN106266693A CN106266693A CN201610796096.6A CN201610796096A CN106266693A CN 106266693 A CN106266693 A CN 106266693A CN 201610796096 A CN201610796096 A CN 201610796096A CN 106266693 A CN106266693 A CN 106266693A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- fructus
- rhizoma
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 241000255791 Bombyx Species 0.000 claims abstract description 9
- 241000756943 Codonopsis Species 0.000 claims abstract description 9
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 241000209140 Triticum Species 0.000 claims abstract description 9
- 235000021307 Triticum Nutrition 0.000 claims abstract description 9
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 9
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 9
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 9
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000796 flavoring agent Substances 0.000 description 28
- 235000019634 flavors Nutrition 0.000 description 28
- 210000002784 stomach Anatomy 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 9
- 230000035922 thirst Effects 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 206010043458 Thirst Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea Chemical compound C=1C(OC)=CC=C(C(C2=O)(C)C)C=1C(=O)N2CCC(C=C1)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 LLJFMFZYVVLQKT-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- 229960003468 gliquidone Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗糖尿病的中药组合物,其组分包括:石膏、知母、生地、芦根、枸杞、沙参、玉竹、天花粉、山萸肉、熟地、僵蚕、淮山药、党参、黄芪、苍术、玄参、淡竹叶、粉葛、黄芩、枳壳、枳实、白术、川牛膝、石斛、夏枯草、鱼腥草、女贞子、麦旱莲、麦冬、黄连。该中药组合物对糖尿病具有较好的疗效。
Description
技术领域
本发明涉及中药组合物技术领域,尤其是涉及一种治疗糖尿病的中药组合物。
背景技术
中医将糖尿病形象的称为“消渴症”。消渴症的成病机理主要是素体阴虚、五脏柔弱,复因饮食不节、过食肥甘、情志失调、劳欲过度而导致肾阴亏虚,肺胃燥热。现代西医认为糖尿病(diabetes)是由遗传因素、免疫功能紊乱、微生物感染、自由基毒素、精神因素等各种致病因子作用于机体导致胰岛功能减退、胰岛素抵抗等所引发的糖、蛋白质、脂肪、水和电解质等一系列代谢紊乱综合征。
糖尿病在临床上以高血糖为主要特点,表现为多尿、多饮、多食、消瘦(即“三多一少”)。糖尿病对人类健康的最大危害是在动脉硬化及微血管病变基础上所产生的更为复杂严重的多种慢性并发症,由此可引起多个器官的功能缺陷和衰竭,尤其眼、肾、神经、心脏、血管等组织的慢性进行性损伤。而一旦发生糖尿病并发症,通常会造成组织器官毁损,甚至致残、致死。
目前,西医治疗糖尿病的药物主要有胰岛素以及磺脲类药物(如D860、达美康、优降糖、糖适平、消渴丸、格列美脲)、双胍类药物(如降糖灵、二甲双胍、消渴灵)、α-糖苷酶抑制剂(如拜糖平)等。这些药物对于控制血糖通常都比较有效,但其也存在药物选用难度大、容易发生降糖药继发性失效、对糖尿病并发症的改善作用较弱等缺陷。
随着人们对中医的逐渐推崇,一些治疗糖尿病的中药制剂在目前受到了不少患者的优先选用。
发明内容
本发明的目的是提供一种治疗糖尿病的中药组合物,它具有对糖尿病有较好的疗效的特点。
本发明所采用的技术方案是:
治疗糖尿病的中药组合物,以重量份计,其组分构成为:
石膏25-35份、知母10-18份、生地16-22份、芦根25-35份、枸杞12-18份、沙参13-16份、玉竹14-17份、天花粉13-17份、山萸肉13-17份、熟地18-22份、僵蚕8-12份、淮山药26-32份、党参28-32份、黄芪28-32份、苍术13-18份、玄参13-18份、淡竹叶13-18份、粉葛28-32份、黄芩10-15份、枳壳8-12份、枳实8-12份、白术13-17份、川牛膝13-18份、石斛13-18份、夏枯草28-32份、鱼腥草28-32份、女贞子28-32份、麦旱莲28-32份、麦冬13-18份、黄连9-12份。
优化的,以重量份计,治疗糖尿病的中药组合物的组分构成为:石膏30份、知母15份、生地20份、芦根30份、枸杞15份、沙参15份、玉竹15份、天花粉15份、山萸肉15份、熟地20份、僵蚕10份、淮山药30份、党参30份、黄芪30份、苍术15份、玄参15份、淡竹叶15份、粉葛30份、黄芩12份枳壳10份、枳实10份、白术15份、川牛膝15份、石斛15份、夏枯草30份、鱼腥草30份、女贞子30份、麦旱莲30份、麦冬15份、黄连10份。
本发明中:
石膏性味甘、辛,大寒,归肺、胃经。主治清热泻火,除烦止渴。
知母性味苦、甘,寒。归肺、胃、肾经。主治清热泻火,生津润燥。可用于高热烦渴、内热消渴。
生地性味甘,寒。归心,肝,肾经。可治小儿热疾,烦渴头痛。
芦根性味甘,寒。归肺、胃经。主治清热生津,除烦,止呕,利尿。用于热病烦渴,胃热呕哕,肺热咳嗽,肺痈吐脓,热淋涩痛。
枸杞性味甘,平。归肝、肾经。主治滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
沙参性味甘,凉。主治清热养阴,润肺止咳。
玉竹性味甘,微寒。归肺、胃经。主治养阴润燥,生津止渴。
天花粉性味甘、微苦,微寒。归肺、胃经。主治清热生津,消肿排脓。用于热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
山萸肉性味酸、涩,微温。归肝、肾经。主治补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱。内热消渴。
熟地味甘,性温,沉也,阴中之阳,无毒。入肝肾二经。生血益精,长骨中脑中之髓。
僵蚕性味咸、辛,平。归肝、肺、胃经。主治祛风定惊,化痰散结。
淮山药性味平、甘、无毒。入肺、脾、肾、胃。主治健脾、厚肠胃、补肺、益肾。
党参性味甘,平。归脾、肺经。主治补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。
黄芪性味甘,温。归肺、脾经。主治补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
苍术性味辛、苦,温。归脾、胃、肝经。主治燥湿健脾,祛风散寒,明目。用于脘腹胀满,泄泻,水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲。
玄参性味甘、苦、咸,微寒。归肺、胃、肾经。主治凉血滋阴,泻火解毒。用于热病伤阴,舌绛烦渴,温毒发斑,津伤便秘,骨蒸劳嗽,目赤,咽痛,瘰疠,白喉,痈肿疮毒。
淡竹叶性味甘、淡,寒。归心、胃、小肠经。主治清热除烦,利尿。用于热病烦渴,小便赤涩淋痛,口舌生疮。
粉葛性味甘、辛,凉。归脾、胃经。主治解肌退热,生津,透疹,升阳止泻。
黄芩性味苦,寒。归肺、胆、脾、大肠、小肠经。主治清热燥湿,泻火解毒,止血,安胎。可用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴等症。
枳壳性味苦、辛、酸,温。归脾、胃经。主治理气宽中,行滞消胀。
枳实性味苦、辛、酸,温。归脾、胃经。主治破气消积,化痰散痞。
白术性味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。
川牛膝性味苦、酸,平。归肝、肾经。主治补肝肾,强筋骨,逐瘀通经,引血下行。
石斛性味甘,微寒。归胃、肾经。主治益胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明。
夏枯草性味辛、苦,寒。归肝、胆经。主治清火,明目,散结,消肿。
鱼腥草性味辛,微寒。归肺经。主治清热解毒,消痈排脓,利尿通淋。
女贞子性味甘、苦,凉。归肝、肾经。主治滋补肝肾,明目乌发。
麦旱莲,又名旱莲草,其全草入药,有凉血、止血、消肿、强壮之功效。
麦冬性味甘,微苦,微寒。归心、肺、胃经。主治养阴生津,润肺清心。可用于肺燥干咳,虚痨咳嗽,津伤口渴,心烦失眠,内热消渴,肠燥便秘。
黄连性味苦,寒。归心、脾、胃、肝、胆、大肠经。主治清热燥湿,泻火解毒。
本发明的治疗糖尿病的中药组合物针对中医对糖尿病的病理分析,根据中医传统理论,采用前述组分经过合理的君臣配伍,具有清热解毒、理气健脾、补肝肾、益精髓、降血糖的功效,且治疗糖尿病见效快、疗程短。
具体实施方式
实施例1
治疗糖尿病的中药组合物,其组分构成为:
石膏25g、知母10g、生地16g、芦根25g、枸杞12g、沙参13g、玉竹14g、天花粉13g、山萸肉13g、熟地18g、僵蚕8g、淮山药26g、党参28g、黄芪28g、苍术13g、玄参13g、淡竹叶13g、粉葛28g、黄芩10g、枳壳8g、枳实8g、白术13g、川牛膝13g、石斛13g、夏枯草28g、鱼腥草28g、女贞子28g、麦旱莲28g、麦冬13g、黄连9g。
前述组分采用常规中药水煎服方法煎为一剂,一剂服两天,一日三次,
十五剂为一疗程。
实施例2
治疗糖尿病的中药组合物,其组分构成为:
石膏30g、知母15g、生地20g、芦根30g、枸杞15g、沙参15g、玉竹15g、天花粉15g、山萸肉15g、熟地20g、僵蚕10g、淮山药30g、党参30g、黄芪30g、苍术15g、玄参15g、淡竹叶15g、粉葛30g、黄芩12g枳壳10g、枳实10g、白术15g、川牛膝15g、石斛15g、夏枯草30g、鱼腥草30g、女贞子30g、麦旱莲30g、麦冬15g、黄连10g。
前述组分采用常规中药水煎服方法煎为一剂,一剂服两天,一日三次,
十五剂为一疗程。
实施例3
治疗糖尿病的中药组合物,其组分构成为:
石膏35g、知母18g、生地22g、芦根35g、枸杞18g、沙参16g、玉竹17g、天花粉17g、山萸肉17g、熟地22g、僵蚕12g、淮山药32g、党参32g、黄芪32g、苍术18g、玄参18g、淡竹叶18g、粉葛32g、黄芩15g、枳壳12g、枳实12g、白术17g、川牛膝18g、石斛18g、夏枯草32g、鱼腥草32g、女贞子32g、麦旱莲32g、麦冬18g、黄连12g。
前述组分采用常规中药水煎服方法煎为一剂,一剂服两天,一日三次,
十五剂为一疗程。
试验例
取家兔30只,雌雄不限,体重1.5--2.5kg,分两组,每组15只,分别为A组和B组。其中,A组随机取实施例1-3的药剂按照1.5倍的常规用量服用,B组随机取实施例1-3的药剂按照常规用量服用,服用方法为灌胃法给药,每天2次,连服一周,每天观察给药反应。结果表明两组家兔活动、饮食均正常,药物无不良毒副作用。
效果例
征集糖尿病患者150名,年龄区间为30-50岁,男性82名。随机将患者均分为3组,分别为第一组、第二组、第三组。其中,第一组按正常量服用实施例1的治疗糖尿病的中药组合物煎成的药剂,第二组按正常量服用实施例2的治疗糖尿病的中药组合物煎成的药剂,第三组按正常量服用实施例3的治疗糖尿病的中药组合物煎成的药剂,且均服用一疗程。结果为:第一组中有41名血糖含量归于正常,第二组中有46名血糖含量归于正常,第三组中有40名血糖含量归于正常,见效率分别为82%、92%和80%,说明本发明的治疗糖尿病的中药组合物对治疗糖尿病有较好的疗效。
以上所述仅为本发明的优选实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (2)
1.治疗糖尿病的中药组合物,以重量份计,其组分构成为:
石膏25-35份、知母10-18份、生地16-22份、芦根25-35份、枸杞12-18份、沙参13-16份、玉竹14-17份、天花粉13-17份、山萸肉13-17份、熟地18-22份、僵蚕8-12份、淮山药26-32份、党参28-32份、黄芪28-32份、苍术13-18份、玄参13-18份、淡竹叶13-18份、粉葛28-32份、黄芩10-15份、枳壳8-12份、枳实8-12份、白术13-17份、川牛膝13-18份、石斛13-18份、夏枯草28-32份、鱼腥草28-32份、女贞子28-32份、麦旱莲28-32份、麦冬13-18份、黄连9-12份。
2.治疗糖尿病的中药组合物,以重量份计,其组分构成为:石膏30份、知母15份、生地20份、芦根30份、枸杞15份、沙参15份、玉竹15份、天花粉15份、山萸肉15份、熟地20份、僵蚕10份、淮山药30份、党参30份、黄芪30份、苍术15份、玄参15份、淡竹叶15份、粉葛30份、黄芩12份枳壳10份、枳实10份、白术15份、川牛膝15份、石斛15份、夏枯草30份、鱼腥草30份、女贞子30份、麦旱莲30份、麦冬15份、黄连10份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610796096.6A CN106266693A (zh) | 2016-08-31 | 2016-08-31 | 治疗糖尿病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610796096.6A CN106266693A (zh) | 2016-08-31 | 2016-08-31 | 治疗糖尿病的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106266693A true CN106266693A (zh) | 2017-01-04 |
Family
ID=57709507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610796096.6A Pending CN106266693A (zh) | 2016-08-31 | 2016-08-31 | 治疗糖尿病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106266693A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224021A (zh) * | 2018-10-29 | 2019-01-18 | 常现辉 | 治疗糖尿病、降血压、降血脂的保健养生茶及制备方法 |
CN112022967A (zh) * | 2020-10-20 | 2020-12-04 | 龙步明 | 一种糖尿病的中药制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083531A (zh) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | 治疗糖尿病的药物 |
CN104042909A (zh) * | 2014-06-28 | 2014-09-17 | 张璟璟 | 一种治疗糖尿病的药物 |
CN105582508A (zh) * | 2016-01-04 | 2016-05-18 | 潘清水 | 一种治疗糖尿病的药物 |
-
2016
- 2016-08-31 CN CN201610796096.6A patent/CN106266693A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083531A (zh) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | 治疗糖尿病的药物 |
CN104042909A (zh) * | 2014-06-28 | 2014-09-17 | 张璟璟 | 一种治疗糖尿病的药物 |
CN105582508A (zh) * | 2016-01-04 | 2016-05-18 | 潘清水 | 一种治疗糖尿病的药物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224021A (zh) * | 2018-10-29 | 2019-01-18 | 常现辉 | 治疗糖尿病、降血压、降血脂的保健养生茶及制备方法 |
CN112022967A (zh) * | 2020-10-20 | 2020-12-04 | 龙步明 | 一种糖尿病的中药制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103690794A (zh) | 一种治疗糖尿病的中药制剂 | |
CN104288651A (zh) | 一种治疗产后缺乳的药物及其制备方法 | |
CN105920514A (zh) | 治疗代谢综合征的中药组合物 | |
CN104013825A (zh) | 一种治疗糖尿病的中药组合物 | |
CN109966462A (zh) | 一种调理体质的膏方及其制备方法 | |
CN103816428B (zh) | 一种有效治疗糖尿病的制剂 | |
CN104189811A (zh) | 一种治疗产后血晕的中药组合物及其制备方法 | |
CN104771725A (zh) | 一种治疗虚寒型糖尿病的药物 | |
CN106266693A (zh) | 治疗糖尿病的中药组合物 | |
CN107412550A (zh) | 一种活血降糖中药汤剂 | |
CN105194295A (zh) | 一种治疗糖尿病的药物组合物 | |
CN104474202B (zh) | 一种治疗厌食的药物组合物 | |
CN104367753A (zh) | 一种治疗2型糖尿病的中药组合物 | |
CN104998074A (zh) | 一种治疗胃病的中药及其制备方法 | |
CN104721580A (zh) | 一种治疗糖尿病的中药组合物 | |
CN109498745A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN103142917A (zh) | 一种治疗慢性肾功能衰竭的药物及其制备方法 | |
CN102058863B (zh) | 一种消除身体水肿的中药组合物 | |
CN105687897A (zh) | 一种治疗糖尿病的纯中药制剂及其制备方法 | |
CN107233528A (zh) | 一种可有效治疗脂肪肝的内服药物及其制备方法 | |
CN106310019A (zh) | 一种治疗肺痿的中药组合物及其制备方法 | |
CN106038994A (zh) | 一种辅助降糖的食药及其制备方法 | |
CN104667241A (zh) | 一种治疗肝外磷代谢病的中药制剂及其制备方法 | |
CN106214941A (zh) | 一种可有效治疗糖尿病的中药组合物及其制备方法 | |
CN105535545A (zh) | 一种治疗苯中毒所致血小板减少症的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
RJ01 | Rejection of invention patent application after publication |